reference/30243921

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30243921

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1985
issn	1556-0864
issueIdentifier	12
pageRange	1977-1985
publicationName	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
startingPage	1977
bibliographicCitation	Schiller JH, von Pawel J, Schütt P, Ansari RH, Thomas M, Saleh M, McCroskey RD, Pfeifer W, Marsland TA, Kloecker GH, Sebastian M, Pirker R, Kurek R, Beadman C, Socinski MA. Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer. J Thorac Oncol. 2010 Dec;5(12):1977–85. doi: 10.1097/jto.0b013e3181f4a5c9. PMID: 20978446.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9f803822c60197c852cdd2af0fbcb42 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60b7c24f42b594a5f7228165f4e7fda1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50c879d107163bd8e878cbe2c90a8b74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d22c958d4e468cb3a5cac45a8d80356c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce301253ffb18df9721beff3cb02ad4d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fed05587b06d3e680b58cfa92e69b86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27d1ef57fc48b978120155b409d971a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2597536e71ee67a0697ac1721de8abf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f29112ac2f9c74d3c48ca9a03b24d5e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0fde319e0bb4367dc6eb9263b0e50fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7e502c8faa38ef94f90bedfe1152602 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_237f5f211847831b67f9204ba82491fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7028dca2ed978294af1b3d12254095a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31b6059662735eda5b6f07878b564eaa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be0af060f59eaa4c3e879b095375b9d2
date	201012
identifier	https://pubmed.ncbi.nlm.nih.gov/20978446 https://doi.org/10.1097/jto.0b013e3181f4a5c9
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33311 https://portal.issn.org/resource/ISSN/1556-0864
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer
discusses	http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0511026 http://id.nlm.nih.gov/mesh/M0556300
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D005971Q000627 http://id.nlm.nih.gov/mesh/D000964Q000627 http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008175Q000523 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006147Q000627 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D002289Q000523 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D006147Q000009 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D066246Q000037 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005971Q000009 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000911Q000009 http://id.nlm.nih.gov/mesh/D006147Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837

Total number of triples: 76.